Security Snapshot

VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) Institutional Ownership

CUSIP: 928661107

13F Institutional Holders and Ownership History from Q1 2015 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

28

Shares (Excl. Options)

16,142,878

Price

$0.26

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
VNRX on NYSE
Shares outstanding
129,251,202
Price per share
$0.20
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
16,142,878
Total reported value
$4,127,281
% of total 13F portfolios
0%
Share change
-9,982,500
Value change
-$6,560,997
Number of holders
28
Price from insider filings
$0.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share is tracked under CUSIP 928661107.
  • 28 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 28 to 5 between Q4 2025 and Q1 2026.
  • Reported value moved from $4,127,281 to $60,158.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 28 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 928661107?
CUSIP 928661107 identifies VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lagoda Investment Management, L.P. 10% -11% $4,387,497 +$290,747 12,535,706 +7.1% Lagoda Investment Management, L.P. 31 Dec 2025
ARMISTICE CAPITAL, LLC 5% -41% $1,612,409 -$732,698 6,449,635 -31% Armistice Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 28 institutional investors reported holding 16,142,878 shares of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX). This represents 12% of the company’s total 129,251,202 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Lagoda Investment Management, L.P. 8.9% 11,463,603 -8.2% 1.7% $2,930,097
VANGUARD GROUP INC 1.2% 1,530,048 0% 0% $391,692
GEODE CAPITAL MANAGEMENT, LLC 0.75% 963,986 +9.8% 0% $246,436
BlackRock, Inc. 0.34% 445,187 0% 0% $113,790
STATE STREET CORP 0.24% 311,538 +16% 0% $79,629
NORTHERN TRUST CORP 0.2% 259,593 +35% 0% $66,352
Silverberg Bernstein Capital Management LLC 0.19% 249,282 +7.4% 0.04% $63,716
CITADEL ADVISORS LLC 0.13% 167,730 -49% 0% $42,872
Squarepoint Ops LLC 0.1% 134,668 0% $34,421
JANE STREET GROUP, LLC 0.09% 111,419 0% $28,479
Virtu Financial LLC 0.08% 108,581 +167% 0% $28,000
Warberg Asset Management LLC 0.07% 90,833 0.01% $23,162
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.04% 56,834 0% $14,527
Bank of New York Mellon Corp 0.04% 55,596 +82% 0% $14,210
GROUP ONE TRADING LLC 0.04% 50,000 0% $12,780
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.03% 39,999 -42% 0% $10,224
RENAISSANCE TECHNOLOGIES LLC 0.02% 25,300 -68% 0% $6,467
Cetera Investment Advisers 0.02% 20,550 +2.5% 0% $5,253
Tower Research Capital LLC (TRC) 0.01% 15,956 +262% 0% $4,078
TWO SIGMA SECURITIES, LLC 0.01% 14,595 0% $3,730
Creative Planning 0.01% 12,834 +28% 0% $3,280
Chicago Partners Investment Group LLC 0.01% 11,999 -26% 0% $3,384
BANK OF AMERICA CORP /DE/ 0% 960 0% 0% $245
MORGAN STANLEY 0% 665 -17% 0% $170
OSAIC HOLDINGS, INC. 0% 430 0% 0% $110

Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 297,815 $60,158 +$9,779 $0.20 5
2025 Q4 16,142,878 $4,127,281 -$6,560,997 $0.26 28
2025 Q3 26,125,378 $17,729,734 +$1,443,851 $0.68 32
2025 Q2 23,985,160 $18,228,005 +$2,275,044 $0.76 28
2025 Q1 21,008,583 $11,976,111 +$1,320,423 $0.57 24
2024 Q4 18,685,542 $11,211,093 +$694,906 $0.60 25
2024 Q3 17,526,713 $10,533,642 +$5,772,495 $0.60 21
2024 Q2 7,992,589 $4,835,640 +$105,463 $0.60 25
2024 Q1 7,785,670 $5,893,961 +$1,077,302 $0.76 22
2023 Q4 6,366,411 $4,564,679 -$68,958 $0.72 27
2023 Q3 6,308,141 $4,346,471 -$837 $0.69 28
2023 Q2 6,463,590 $8,987,624 -$52,721 $1.39 33
2023 Q1 6,416,306 $12,217,662 +$399,692 $1.91 38
2022 Q4 6,193,332 $15,049,871 +$949,239 $2.43 32
2022 Q3 5,897,630 $8,020,360 -$142,068 $1.36 29
2022 Q2 5,960,129 $12,218,718 -$261,633 $2.05 29
2022 Q1 6,068,762 $18,268,044 +$372,253 $3.01 31
2021 Q4 5,943,349 $18,664,090 -$668,950 $3.14 34
2021 Q3 6,181,288 $19,161,762 -$902,699 $3.10 35
2021 Q2 6,517,172 $21,444,255 -$7,570,608 $3.29 42
2021 Q1 8,718,962 $32,953,841 +$4,430,716 $3.78 53
2020 Q4 7,545,557 $29,349,911 +$2,774,788 $3.89 45
2020 Q3 6,842,462 $21,961,861 +$1,360,270 $3.21 45
2020 Q2 6,380,058 $24,816,004 +$11,885,556 $3.89 53
2020 Q1 3,340,850 $10,391,448 +$296,700 $3.11 29
2019 Q4 3,171,123 $15,028,166 +$110,802 $4.74 36
2019 Q3 3,109,395 $17,472,952 +$603,068 $5.62 31
2019 Q2 3,028,559 $9,510,646 -$60,425 $3.14 25
2019 Q1 3,046,008 $9,899,369 +$990,393 $3.25 26
2018 Q4 2,755,859 $4,986,901 -$1,175,482 $1.81 25
2018 Q3 3,211,934 $8,401,029 -$3,165,078 $2.59 25
2018 Q2 4,441,353 $8,888,150 -$492,117 $2.00 24
2018 Q1 4,665,394 $11,196,780 +$281,528 $2.40 24
2017 Q4 4,547,367 $13,369,331 -$275,277 $2.94 18
2017 Q3 4,670,127 $12,311,292 -$633,747 $2.63 19
2017 Q2 4,904,719 $17,350,000 +$817,919 $3.54 17
2017 Q1 4,673,715 $18,787,000 -$465,453 $4.01 17
2016 Q4 4,798,201 $21,910,000 +$1,445,213 $4.57 16
2016 Q3 4,478,056 $23,862,000 +$7,568,562 $5.30 16
2016 Q2 3,067,113 $9,659,000 +$59,819 $3.14 14
2016 Q1 3,046,217 $10,814,000 +$7,611,391 $3.55 14
2015 Q4 899,396 $4,048,000 -$220,209 $4.51 12
2015 Q3 948,073 $4,246,000 +$430,027 $4.46 8
2015 Q2 854,891 $3,376,000 -$143,145 $3.93 6
2015 Q1 889,690 $3,656,000 +$3,656,000 $4.10 8
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .